The Case for Emerging Markets When Almost No One Wants Them

The S&P 500’s Shiller CAPE ratio sits at roughly 42 as of mid-2026, within striking distance of the dot-com peak and well above the levels that have historically preceded compressed long-run returns. Meanwhile, cyclically adjusted valuations across a broad basket of emerging market equities remain close to single-digit or low-teen multiples, a gap of roughly 30 or more CAPE points that has few precedents in the post-MSCI era. Investors who keep 100 percent of their equity allocation in US markets are not simply expressing confidence in American companies. They are implicitly betting that this gap never closes, or that it closes only because EM disappoints rather than because the US mean-reverts. That is a strong bet, and it deserves to be made consciously rather than by default.

Why the Valuation Gap Is the Central Argument

Valuation is not a timing tool. As we have explored in depth elsewhere on this site, a high Shiller CAPE cannot tell you whether markets fall next quarter or grind higher for another three years. What it does tell you, with unusually high statistical reliability at a ten-year horizon, is the approximate price you are paying for the next decade of earnings. Pay less, receive more. The relationship holds not just in the United States but across international markets, and there is no strong reason to think it breaks down at the EM level.

Research from multiple quantitative investment firms, including published work by Research Affiliates, has documented that starting CAPE values in emerging market indices carry similar long-run predictive power for subsequent returns as they do in developed markets. When aggregate EM valuations sit near or below their own long-run historical averages while US valuations sit near all-time highs, the implied return gap over the following decade is substantial. Vanguard’s long-term capital markets forecasts have repeatedly placed expected EM returns several percentage points above expected US equity returns in precisely this kind of environment, citing more attractive valuations and higher dividend yields as the primary drivers.

Paying a CAPE of 12 for a broad market and a CAPE of 42 for another is not a diversification decision. It is a valuation decision in disguise. Every dollar allocated between the two is also a vote on which starting price leads to better outcomes over the following decade.

The current 10-year US Treasury yield of 4.43 percent further complicates the US equity case. The earnings yield on a market trading at a CAPE of 42 is roughly 2.4 percent in real terms, well below the risk-free rate and well below what investors would historically have accepted as an equity risk premium. In EM markets where CAPE-equivalent measures cluster in the low-to-mid teens, the implied earnings yields are meaningfully higher, and the equity risk premium over local or dollar-denominated rates remains far more attractive.

What Decades of Factor Research Shows for EM

The case for EM is not just a macro valuation argument. It is corroborated by factor evidence. Academic research using the S&P/IFC Emerging Markets database, covering monthly total returns across a broad set of developing economies, found that value strategies based on earnings yield and book-to-market ratios produced reliably positive excess returns in EM just as they did in developed markets. Critically, the value premium in emerging markets appeared after controlling for risk, suggesting it was not simply compensation for taking on obviously riskier assets.

The same body of research confirmed a size premium in EM: smaller-capitalization companies across the dataset generated higher average returns than large-cap peers, consistent with findings in developed markets. The combined value-and-small-cap tilt in emerging markets has historically been additive, which matters for investors who are not content to hold a pure market-cap-weighted EM index but want to apply a quality screen or a factor orientation within that allocation.

None of this means EM always wins. There are multi-year stretches, sometimes measured in a decade or more, where emerging markets lag their developed peers badly. The 2010s were essentially a full decade of US equity dominance, driven by a combination of genuine earnings growth from US technology companies, multiple expansion, and dollar strength. Investors who held EM through that period experienced both the underperformance and the psychological pressure that comes with watching a position sit flat while domestic indices compound aggressively. The long-run case survives precisely because that kind of patience is so difficult that most investors never maintain it.

The Demographic Argument: Slow, Durable, Underpriced

Behind the valuation numbers lies a structural growth story that does not appear on quarterly earnings calls. India’s working-age population continues to expand for decades to come at a pace no major developed economy can match. Southeast Asia, home to hundreds of millions of people across Vietnam, Indonesia, the Philippines, Thailand, and their neighbors, contains an emerging consumer class whose disposable income growth is projected to outpace Western economies well into the middle of the century. Sub-Saharan Africa, often overlooked in institutional allocation frameworks, has the youngest population of any region on earth and the fastest-growing urban middle class by percentage terms.

Demographics are not an equity signal in the short term. Economic growth and stock market returns famously decouple over short periods, and high nominal GDP growth can actually be associated with poor equity returns if starting valuations are elevated or if growth flows to labor and state rather than to shareholders. The serious version of the demographic argument is not that young populations guarantee stock market gains. It is that demographics create the conditions for sustained consumer demand, productivity growth, and capital deepening over periods of 20 to 40 years, and that this duration of tailwind is not adequately priced into a market trading at 12 times cyclically adjusted earnings.

India deserves specific mention because it has become the world’s most populous country, is constructing physical and digital infrastructure at a pace visible from satellite imagery, and is attracting manufacturing investment from companies seeking geographic diversification away from China. The Indian equity market carries higher valuations than most other EM peers, reflecting some of this optimism, but the underlying growth trajectory remains among the most compelling in the investable world. A broad MSCI Emerging Markets index already allocates heavily to India, which means investors accessing EM through a standard low-cost ETF gain exposure automatically.

Governance Progress: Real but Uneven

The single most persistent criticism of emerging markets as an allocation is governance: minority shareholder rights, state intervention, accounting opacity, and the risks of political expropriation. These concerns have historically been legitimate, and they have justified a permanent valuation discount relative to markets with stronger institutional frameworks. The question worth asking now is whether the discount still matches the risk.

Governance quality across major EM economies has improved materially over the past two decades, measured by World Bank rule-of-law indices, MSCI governance scores, and the expansion of independent audit and disclosure requirements in markets from Brazil to South Korea. This improvement has not been linear or uniform. China’s state capitalism has become more assertive in some respects even as its listed companies have adopted more sophisticated disclosure practices. India’s corporate governance framework has strengthened considerably under SEBI reforms. Brazil has gone through governance crises and recoveries that serve as a reminder of how quickly institutional quality can deteriorate.

Governance risk in emerging markets is real, but it is not static. Investors who dismissed EM a decade ago based on governance concerns that have since partially resolved paid a meaningful opportunity cost. Investors who dismiss current governance progress as superficial may be making the same error in reverse.

The practical implication is not to ignore governance but to be selective about where governance matters most for your specific exposure. A diversified MSCI EM index blends markets with widely varying governance quality, from Taiwan and South Korea, which meet or approach developed market standards, to markets where state interference risk remains elevated. A quality screen layered onto an EM allocation, whether through an index that filters for companies with higher return-on-equity thresholds and lower state ownership, or through a tilt toward markets ranked higher on rule-of-law indicators, is a sensible way to capture the valuation opportunity without concentrating in the most governance-challenged corners of the opportunity set.

Sizing EM: What Survives a Bear Market

Emerging market equities are meaningfully more volatile than US or developed market equities. During the 2008 financial crisis, the MSCI Emerging Markets index suffered drawdowns far more severe than US equities, forcing capitulation from investors who had entered without a conviction grounded in long-term valuation. During the 2015 Chinese equity shock and the 2018 EM currency crisis, the drawdowns were severe enough to test any holder whose position size exceeded their genuine conviction. An allocation that is intellectually defensible at 15 percent of an equity portfolio can become psychologically impossible to hold if the investor did not genuinely model the possibility of that sleeve falling by half or more while domestic equities fall only a fraction as much.

The sizing question is therefore as much about temperament as about expected returns. A baseline allocation worth genuine respect is somewhere between 10 and 15 percent of the total equity portfolio for an investor with a 20-plus year time horizon, broadly consistent with EM’s approximate weight in a global all-country index and reflective of the valuation gap argument without making a leveraged bet on a single thesis. Below that range, the diversification benefit is modest. Above 25 percent, you are making a concentrated country-risk argument that belongs in the active management column rather than the passive allocation column.

Dollar-cost averaging into an EM position over 12 to 18 months, rather than deploying in one lump sum, reduces the impact of timing and aligns with the psychological reality of how most investors build positions. It also dovetails naturally with the kind of signal-aware approach this site covers elsewhere: for investors who use the 200-week SMA as a long-cycle trend filter, applying that lens to the MSCI EM index or a representative broad ETF provides an additional structural check before committing a full position.

The Quality Screen in Practice

For investors who want more than a plain market-cap-weighted EM index, a quality screen is the most evidence-supported overlay available. Quality, in this context, means companies with persistently high return on invested capital, low debt relative to operating earnings, and genuine free cash flow generation rather than earnings driven by accounting choices. These characteristics are particularly valuable in EM because they tend to separate companies with durable competitive moats from state-connected enterprises whose profitability depends on regulatory protection or subsidized capital.

Funds tracking quality-factor variants of the MSCI Emerging Markets index have historically shown better risk-adjusted returns than plain EM cap-weighted indices, with particular advantage during EM bear markets where the governance and financial distress risks of weaker companies are most exposed. The cost is typically a marginally higher expense ratio and some tracking error relative to the broad MSCI EM benchmark, but for long-term allocators the trade-off is rational. This is not active management in the traditional sense. It is passive exposure to a deliberately designed factor tilt with a credible theoretical and empirical underpinning, comparable in logic to a small-cap value tilt within US equities.

A related approach is geographic tilting within EM: overweighting markets with stronger institutional frameworks and more transparent corporate governance, such as Taiwan and South Korea, relative to their cap-weight in the broad index, while underweighting markets where state interference creates outsized idiosyncratic risk. Some index providers have constructed such tilts systematically. The key is that any deliberate deviation from the cap-weighted EM index carries an implicit active bet, and that bet should be acknowledged and sized accordingly rather than presented as mere prudence.

The goal of a quality screen is not to find the best EM stocks. It is to avoid the worst governance outcomes while still capturing the valuation and growth tailwinds that make the asset class worth owning in the first place.

Patience as the Non-Negotiable Requirement

Every year that US equities outperform emerging markets, the number of investors willing to defend an EM allocation shrinks. This is almost definitionally true of any contrarian position: as underperformance extends, the consensus swings further toward the view that the thesis was simply wrong. The investor who sold EM in 2019 after a difficult decade looked prescient in 2020 and 2021 as US tech dominated. The investor who sold after 2022’s EM rout looked equally prescient in 2023. At each of these exit points, the valuation gap had widened further, meaning the expected forward return had improved, not deteriorated. Selling a cheap asset because it has stayed cheap is one of the most reliably value-destroying behaviors in portfolio management, and it manifests most visibly in EM allocations.

Research on patient, concentrated investors shows that the premium to holding unpopular assets accrues almost entirely to investors who can hold through the period of maximum discomfort. This is a point Charlie Munger made repeatedly in various forms: most of the returns in a long-held position accrue during the phase when the position looks most embarrassing. EM is not a position designed to look good at every quarterly review. It is a position designed to look right over a full market cycle, and the condition for its working is that the investor does not exit during the cycle’s trough.

The Shiller CAPE on the S&P 500 at 42 is not a guarantee that US equities fall. It is a strong signal, backed by more than a century of data, that long-run US equity returns from this starting point are likely to be modest. The same data tradition says that markets trading at lower starting valuations, all else reasonably equal, have historically rewarded long-term holders. Emerging markets, taken as a category, combine that valuation advantage with demographic depth, improving governance, and the persistent factor premia that researchers have documented across multiple datasets. The asset class is unpopular. Given the logic above, that may be close to the best reason to own it.

Frequently Asked Questions

Q: Why do emerging markets consistently trade at a valuation discount to developed markets?

A: Several factors drive the persistent discount: higher political and regulatory risk, less transparent corporate governance, greater currency volatility, and the historically lower institutional quality of legal systems that protect minority shareholders. Some of this discount is genuinely justified. But the discount also tends to overshoot during periods of EM underperformance, when investor sentiment is most negative, creating the conditions where the forward return gap is widest and the contrarian case is strongest.

Q: How should a long-term index investor access emerging markets most efficiently?

A: A broad, low-cost ETF tracking the MSCI Emerging Markets index gives diversified exposure to a wide range of companies across dozens of countries at competitive expense ratios. Investors who want to apply a quality screen can use ETFs explicitly tracking quality-factor variants of the MSCI EM index at a modestly higher cost. Either approach is far more efficient than selecting individual EM country funds or single-stock positions, where governance and liquidity risks are concentrated rather than diversified.

Q: Does economic growth in emerging markets actually translate into equity returns?

A: Not automatically, and the mismatch between GDP growth rates and equity returns is one of the more thoroughly documented puzzles in international finance. High nominal growth can be absorbed by new share issuance that dilutes existing holders, consumed by labor rather than capital, or eroded by inflation and currency depreciation. The channel through which EM demographic tailwinds most reliably boost equity returns is corporate earnings growth over multi-decade periods, particularly in consumer-facing industries as middle-class spending power rises. This is why the valuation argument matters: you need to pay the right price for even genuine growth, or the return disappears into the starting multiple.

Q: Is a 10 to 15 percent EM allocation appropriate for investors closer to retirement?

A: It depends heavily on total portfolio duration and equity weighting. For a 60-year-old with a 30-year spending horizon and a meaningful equity allocation, a position in that range is defensible and broadly consistent with global market weights. For someone within five years of needing to draw down assets significantly, the higher volatility of EM equities creates sequence-of-returns risk that warrants a more conservative stance. The key is that any EM allocation should be sized to survive a severe drawdown in that sleeve without forcing a behaviorally driven exit at the worst possible time.